AT203900T - aerosol formulations chlorofluorocarbons hydrocarbon Free - Google Patents

aerosol formulations chlorofluorocarbons hydrocarbon Free

Info

Publication number
AT203900T
AT203900T AT95101761T AT95101761T AT203900T AT 203900 T AT203900 T AT 203900T AT 95101761 T AT95101761 T AT 95101761T AT 95101761 T AT95101761 T AT 95101761T AT 203900 T AT203900 T AT 203900T
Authority
AT
Austria
Prior art keywords
aerosol formulations
hydrocarbon free
chlorofluorocarbons
chlorofluorocarbons hydrocarbon
free
Prior art date
Application number
AT95101761T
Other languages
German (de)
Inventor
Julianne Berry
Imtiaz A Chaudry
Joel A Sequeira
Michael Kopcha
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US71278991A priority Critical
Application filed by Schering Corp filed Critical Schering Corp
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24863572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT203900(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of AT203900T publication Critical patent/AT203900T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/30Materials not provided for elsewhere for aerosols
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/826Asthma
AT95101761T 1991-06-10 1992-06-08 aerosol formulations chlorofluorocarbons hydrocarbon Free AT203900T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US71278991A true 1991-06-10 1991-06-10

Publications (1)

Publication Number Publication Date
AT203900T true AT203900T (en) 2001-08-15

Family

ID=24863572

Family Applications (4)

Application Number Title Priority Date Filing Date
AT02022987T AT339952T (en) 1991-06-10 1992-06-08 Fluorochlorochemino hydrogen-free aerosol formulations
AT95101761T AT203900T (en) 1991-06-10 1992-06-08 aerosol formulations chlorofluorocarbons hydrocarbon Free
AT95101762T AT226067T (en) 1991-06-10 1992-06-08 aerosol formulations chlorofluorocarbons hydrocarbon Free
AT92913922T AT132368T (en) 1991-06-10 1992-06-08 aerosol formulations Fluorchlorkohlenwasserstoffreie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02022987T AT339952T (en) 1991-06-10 1992-06-08 Fluorochlorochemino hydrogen-free aerosol formulations

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT95101762T AT226067T (en) 1991-06-10 1992-06-08 aerosol formulations chlorofluorocarbons hydrocarbon Free
AT92913922T AT132368T (en) 1991-06-10 1992-06-08 aerosol formulations Fluorchlorkohlenwasserstoffreie

Country Status (24)

Country Link
US (2) US6503482B1 (en)
EP (7) EP0656205B1 (en)
JP (1) JPH06508149A (en)
CN (1) CN1067579A (en)
AT (4) AT339952T (en)
AU (1) AU2178992A (en)
CA (1) CA2111003A1 (en)
CZ (1) CZ271393A3 (en)
DE (7) DE69231991T2 (en)
DK (1) DK1277467T3 (en)
ES (3) ES2158908T3 (en)
FI (1) FI935463A0 (en)
HU (1) HUT67445A (en)
IE (1) IE921848A1 (en)
IL (1) IL102130D0 (en)
MX (1) MX9202751A (en)
NO (2) NO934499D0 (en)
NZ (1) NZ243062A (en)
OA (1) OA9827A (en)
PT (1) PT1277467E (en)
SK (1) SK140593A3 (en)
WO (1) WO1992022287A1 (en)
YU (1) YU59192A (en)
ZA (1) ZA9204163B (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New speed gases and their use in medicine preparations
MX9203481A (en) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulations.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DE69205177D1 (en) * 1991-12-12 1995-11-02 Glaxo Group Ltd A pharmaceutical aerosol formulation.
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
AT171865T (en) 1991-12-12 1998-10-15 Glaxo Group Ltd drug
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DE69232034T2 (en) 1991-12-18 2002-06-06 Minnesota Mining & Mfg Aerosol compositions for drug suspensions
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
AU699677B2 (en) * 1992-07-31 1998-12-10 Glaxo Group Limited Surfactant free aerosol formulations containing beclomathasone dipropionate
MX9304585A (en) * 1992-07-31 1994-03-31 Glaxo Group Ltd pharmaceutical aerosol formulation, suitable for delivering lata the formulation and metered dose inhaler comprising a can.
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
DE4322703A1 (en) * 1993-07-08 1995-01-12 Asta Medica Ag Aerosols using polyoxyethylene glyceryl fettsäureestern as suspension stabilizers and valve lubricants
DE69424181T2 (en) * 1993-12-20 2000-10-19 Minnesota Mining & Mfg aerosol formulations flunisolide
PE44995A1 (en) * 1994-01-27 1995-12-18 Schering Corp Mometasone furoate for the treatment of pulmonary diseases and airway
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
AU709783B2 (en) * 1994-03-14 1999-09-09 Abbott Laboratories Aerosol drug formulations containing vitamin E
GB9405594D0 (en) * 1994-03-22 1994-05-11 Ici Plc Cooling compositions
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
CA2206782C (en) * 1994-12-22 2007-04-03 Astra Aktiebolag Aerosol drug formulations
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
DE19616573C2 (en) 1996-04-25 1999-03-04 Pari Gmbh Using subcritical propellant mixtures and aerosols for micronisation of drugs using dense gases
CN1245982C (en) 1996-05-09 2006-03-22 阿姆瑞德手术有限公司 Treatment of asthma and airway diseases
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
SA548B1 (en) * 1996-08-29 2006-01-31 سكيرنج كوربورشن Spray formulations antenna Mhumicaazon Vuorat mometasone furoate free of CFC chlorofluorocarbon
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
KR20000069275A (en) * 1996-12-04 2000-11-25 새들러 테리 아이언 pharmaceutical compositions and devices for their administration
US6284226B1 (en) * 1997-03-14 2001-09-04 Fujisawa Pharmaceutical Co., Ltd. Aerosol composition containing middle-chain fatty acid triglyceride dispersant
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
AT216244T (en) * 1997-10-09 2002-05-15 Schering Corp Mometasone suspensions for spraying
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AT503687T (en) * 2002-08-27 2011-04-15 Schering Corp Method for producing formulations for measuring doses of inhalers
CN102610189B (en) 2002-10-31 2015-02-18 株式会社半导体能源研究所 Display device and controlling method thereof
KR101166955B1 (en) * 2002-12-10 2012-07-19 선오비온 파마슈티컬스 인코포레이티드 Levalbuterol salt
EP1663159A4 (en) * 2003-09-10 2010-06-09 Map Pharmaceuticals Inc Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation
MXPA06004331A (en) * 2003-10-20 2006-06-05 Schering Corp Pharmaceutical compositions.
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
PL1711164T3 (en) * 2004-01-21 2010-09-30 Merck Sharp & Dohme Method of treating acute rhinosinusitis
CN101098714B (en) * 2004-11-24 2011-09-28 美邦特保健有限公司 Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
WO2007020204A2 (en) * 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
WO2007095039A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
CN100446770C (en) 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 Water aerosol containing beclomethasone dipropionate
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
JP6374682B2 (en) * 2013-09-09 2018-08-15 花王株式会社 Muscle atrophy inhibitor
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (en) 1956-03-21 1900-01-01
US2885427A (en) 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US3320125A (en) 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
FR4699M (en) 1964-07-17
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
NL7708731A (en) 1976-08-13 1978-02-15 Montedison Spa A process for the preparation of new propellant compositions for aerosols.
US4129603A (en) 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
US4311863A (en) 1980-06-11 1982-01-19 E. I. Du Pont De Nemours & Company Process for the manufacture of 1,1,1,2-tetrafluoroethane
DE3260474D1 (en) 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
DE3246081C2 (en) * 1982-12-13 1990-05-31 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
CA1293929C (en) * 1986-03-10 1992-01-07 Kurt Burghart Pharmaceutical composition containing nifedipine
US4851595A (en) 1987-07-07 1989-07-25 E. I. Du Pont De Nemours And Company Liquid phase halogen exchange process for the manufacture of 1,1,1,2-tetrafluoroethane
US4967024A (en) 1988-06-23 1990-10-30 E. I. Du Pont De Nemours And Company Catalyzed hydrofluorination process
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828544D0 (en) 1988-12-07 1989-01-11 Ici Plc Chemical process
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
DE3905726A1 (en) 1989-02-24 1990-08-30 Hoechst Ag Aerosol and propellant for aerosols
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
AU633584B2 (en) 1989-06-15 1993-02-04 Tokyo Tanabe Company Limited Aerosols of pyrido(1,2-a)pyrimidine compounds
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Aerosol propellant compositions
DE4003272A1 (en) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New gas mixtures and their use in medicine preparations
DE69109284D1 (en) * 1990-03-23 1995-06-01 Minnesota Mining & Mfg Use of fluorinated soluble surfactants for the preparation of aerosol medicaments metered dose.
AU650463B2 (en) 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
AU649702B2 (en) * 1990-06-28 1994-06-02 Glaxo Inc. Aerosol drug formulations
AT147973T (en) * 1990-06-29 1997-02-15 Fisons Plc Pressurized aerosol composition
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
DE4038203C2 (en) * 1990-11-30 1992-11-26 Kali-Chemie Pharma Gmbh, 3000 Hannover, De
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP1092430B1 (en) * 1991-06-10 2003-08-06 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
AT171865T (en) 1991-12-12 1998-10-15 Glaxo Group Ltd drug
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DE69232034T2 (en) 1991-12-18 2002-06-06 Minnesota Mining & Mfg Aerosol compositions for drug suspensions
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants

Also Published As

Publication number Publication date
IE921848A1 (en) 1992-12-16
FI935463D0 (en)
EP0587790B2 (en) 2000-03-08
PT1277467E (en) 2006-12-29
CN1067579A (en) 1993-01-06
EP0656205A1 (en) 1995-06-07
EP0653205A1 (en) 1995-05-17
CA2111003A1 (en) 1992-12-23
AT132368T (en) 1996-01-15
EP0587790A1 (en) 1994-03-23
DE69232818T2 (en) 2003-06-18
HUT67445A (en) 1995-04-28
EP1736147A3 (en) 2007-10-17
DK1277467T3 (en) 2007-01-15
ZA9204163B (en) 1993-02-24
AU2178992A (en) 1993-01-12
EP0653205B1 (en) 2002-10-16
CZ271393A3 (en) 1994-07-13
US6503482B1 (en) 2003-01-07
WO1992022287A1 (en) 1992-12-23
IL102130D0 (en) 1993-01-14
OA9827A (en) 1994-04-15
DE69233659D1 (en) 2006-11-02
EP1277467A2 (en) 2003-01-22
EP0587790B1 (en) 1996-01-03
EP1277467B1 (en) 2006-09-20
AT226067T (en) 2002-11-15
YU59192A (en) 1994-12-28
ES2158908T3 (en) 2001-09-16
DE69231991D1 (en) 2001-09-13
FI935463A (en) 1993-12-07
EP1736147A2 (en) 2006-12-27
NO934499D0 (en) 1993-12-09
EP1277467A3 (en) 2003-04-16
SK140593A3 (en) 1994-11-09
FI935463A0 (en) 1993-12-07
DE69207409D1 (en) 1996-02-15
DE69232818D1 (en) 2002-11-21
EP0656205B1 (en) 2001-08-08
NO934499L (en) 1993-12-09
JPH06508149A (en) 1994-09-14
US6416743B1 (en) 2002-07-09
DE69231991T2 (en) 2002-04-04
DE69233659T2 (en) 2007-09-13
EP0518601A1 (en) 1992-12-16
NZ243062A (en) 1993-09-27
AT339952T (en) 2006-10-15
ES2269582T3 (en) 2007-04-01
MX9202751A (en) 1992-12-01
EP1005860A1 (en) 2000-06-07
ES2180592T3 (en) 2003-02-16

Similar Documents

Publication Publication Date Title
DE69231526T2 (en) shaving
DE69224531D1 (en) shaving
DE69424181T2 (en) aerosol formulations flunisolide
DE69219633T2 (en) trocar
ITMI921588A1 (en) Bisbenzofuran-2-ones
DK0652758T3 (en) Diferitoxin vaccines
FI945490A0 (en) dispenser
AT213259T (en) Foamed materials injection-
FI933594A0 (en) Kanalbenaemningsapparat Foer I televisionsmottagare
DK0484530T3 (en) foamable aerosol
FI925521A (en) Foerbaettrad tillslutningskonstruktion Foer I oegonlinsform
DK0514749T3 (en) hand Bruse
DE69413387T2 (en) An aerosol dispenser
FI931513A0 (en) Kontrollrum Foer en kompakt arbetsstation
NO930189D0 (en) Tioeterkonjugat
NO944377D0 (en) Kjölemiddelblandinger
NO933319L (en) Produksjonsnippel
NO930819D0 (en) Sulfonamidokarboksamider
DK0656206T3 (en) Aerosol formulations without chlorofluorocarbons
NO932695L (en) Deoksytaksoler
NO932705D0 (en) Smoereoljer
DE69316999D1 (en) dispenser
NO308726B1 (en) Dispensing system
DE69317301T2 (en) dispenser
DE69415039T2 (en) tape dispenser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties